Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glucose and Cell Context-Dependent Impact of BMI-1 Inhibitor PTC-209 on AKT Pathway in Endometrial Cancer Cells. | Cancers (Basel) | 2022 | 36497428 | PubTator, text mining | PubMed |
| Dickkopf-3: An Update on a Potential Regulator of the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36497305 | PubTator, text mining | PubMed |
| Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism. | Front Oncol | 2022 | 36483029 | PubTator, text mining | PubMed |
| Evolutionarily conserved gene expression patterns for affective disorders revealed using cross-species brain transcriptomic analyses in humans, rats and zebrafish. | Sci Rep | 2022 | 36460699 | PubTator, text mining | PubMed |
| miR-23b-3p regulates differentiation of osteoclasts by targeting PTEN via the PI3k/AKT pathway. | Arch Med Sci | 2022 | 36457973 | PubTator, text mining | PubMed |
| Methylation differences in Alzheimer's disease neuropathologic change in the aged human brain. | Acta Neuropathol Commun | 2022 | 36447297 | PubTator, text mining | PubMed |
| Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-β superfamily signaling module in bone and osteoporosis. | Cell Commun Signal | 2022 | 36443839 | PubTator, text mining | PubMed |
| MicroRNAs as a possible biomarker in the treatment of multiple sclerosis. | IBRO Neurosci Rep | 2022 | 36439971 | PubTator, text mining | PubMed |
| Integrated bioinformatics-based identification of diagnostic markers in Alzheimer disease. | Front Aging Neurosci | 2022 | 36437991 | PubTator, text mining | PubMed |
| Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs). | Int J Mol Sci | 2022 | 36430728 | PubTator, text mining | PubMed |
| Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints. | Cancers (Basel) | 2022 | 36428727 | PubTator, text mining | PubMed |
| Exosomal lncRNA HOTAIR induce macrophages to M2 polarization via PI3K/ p-AKT /AKT pathway and promote EMT and metastasis in laryngeal squamous cell carcinoma. | BMC Cancer | 2022 | 36424539 | PubTator, text mining | PubMed |
| MicroRNAs as immune regulators and biomarkers in tuberculosis. | Front Immunol | 2022 | 36389769 | PubTator, text mining | PubMed |
| microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection. | Front Cell Infect Microbiol | 2022 | 36389170 | PubTator, text mining | PubMed |
| MLN2238 exerts its anti-tumor effects via regulating ROS/JNK/mitochondrial signaling pathways in intrahepatic cholangiocarcinoma. | Front Pharmacol | 2022 | 36386204 | PubTator, text mining | PubMed |
| Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens. | Biochem J | 2022 | 36383217 | PubTator, text mining | PubMed |
| Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy. | Int J Mol Sci | 2022 | 36361831 | PubTator, text mining | PubMed |
| Siglec-6 Signaling Uses Src Kinase Tyrosine Phosphorylation and SHP-2 Recruitment. | Cells | 2022 | 36359823 | PubTator, text mining | PubMed |
| Aberrant B Cell Signaling in Autoimmune Diseases. | Cells | 2022 | 36359789 | PubTator, text mining | PubMed |
| The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer's Disease: Therapeutic Implications and Future Perspectives. | Antioxidants (Basel) | 2022 | 36358538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=23